The purpose of this study was the appraisal of the clinical and functional consequences of germline mutations within the gene for the IL-2 inducible T-cell kinase, ITK. Among patients with Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD), negative for mutations in SH2D1A and XIAP (n ¼ 46), we identified two patients with R29H or D500T,F501L,M503X mutations, respectively. Human wild-type (wt) ITK, but none of the mutants, was able to rescue defective calcium flux in murine Itk À/À T cells. Pulse-chase experiments showed that ITK mutations lead to varying reductions of protein half-life from 25 to 69% as compared with wt ITK (107 min). The pleckstrin homology domain of wt ITK binds most prominently to phosphatidylinositol monophosphates (PI(3)P, PI(4)P, PI(5)P) and to lesser extend to its double or triple phosphorylated derivates (PIP2, PIP3), interactions which were dramatically reduced in the patient with the ITK R29H mutant. ITK mutations are distributed over the entire protein and include missense, nonsense and indel mutations, reminiscent of the situation in its sister kinase in B cells, Bruton's tyrosine kinase.
INTRODUCTION
The IL-2 inducible T-cell kinase (ITK) was first described in the early 90s when three groups independently showed that its mRNA becomes strongly upregulated in T cells stimulated by IL-2.
1--3 Even though wild-type (wt) ITK is first and foremost expressed in T cells and mast cells only, its coding region is affected by acquired activating point mutations in diverse human cancers, 4 not only in T-cell malignancies. The T-cell kinase ITK can be regarded as 'brother or sister kinase' of Bruton's tyrosine kinase (BTK), which is specifically expressed in B cells and instrumental for their undisturbed development, differentiation and signaling. Inherited hemizygous germline BTK mutations were among the first molecularly defined primary immunodeficiency disorders and more than thousand different BTK mutations have been identified in patients with X-linked agammaglobulinemia including missense, nonsense or splice site mutations (see http://bioinf.uta.fi/BTKbase/). 5, 6 In contrast, biallelic germline ITK mutations were more recently identified as the cause for severe Epstein-Barr virus -associated lymphoproliferative diseases (EBV-LPD). We identified two sisters whose T-cell immune response against EBV was severely impaired, leading to their death at the age of 7 and 10 years, respectively. 7 Our clinical observation was in good accordance with a severely compromised T-cell function against EBV, but the degree of the ITK malfunction
has not yet been proven at the molecular level. To some extend the function of ITK is characterized in mice, and knockout studies have revealed its paramount importance for proper T-cell development, T-cell receptor (TCR) signaling, cytokine release and regulation of differentiation. 8 --11 Accordingly, Itk À/À mice show impaired immune response when infected with Toxoplasma gondii or Schistosoma mansoni eggs. 12, 13 Itk À/À mice and the few patients with ITK mutations analyzed so far both show almost complete absence of invariant natural killer T cells, indicating its crucial role in the development and survival of this tiny, highly specialized cell population. However, the ubiquitous B-cell pathogen in the human population throughout the world, the Epstein Barr virus, does not infect mouse B cells. It is therefore an open question to what extent the Itk À/À mice resemble the clinical situation in humans with germline mutations in ITK. Thus, we wanted to know whether ITK mutations are specifically accompanied by severe disturbance of the immune control against EBV or if patients have clinical signs of broader, more general T-cell defects making them prone to other virus infections, autoimmunity or non-EBV-associated cancer. Moreover, it is unknown which types of mutations occur, where such mutations reside in the protein and what their functional and biochemical consequences are. In this study, we addressed some of these questions and functionally characterized two new (R29H and D500T,F501L,M503X) and the two known (R335W and Y588X) ITK mutations. Our data strongly argue for a loss-of-function mechanism although to a varying degree.
MATERIALS AND METHODS
The studies were reviewed and approved by the institutional review board (ethics committee) of Heinrich Heine University, Dusseldorf, Germany. The parents gave informed consent to carry out the investigations described below.
The microarray data have been deposited in NCBI's Gene Expression Omnibus 14 and are accessible through GEO Series accession number GSE28200 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc ¼ GSE28200). ) were generated by PCR. All of these constructs were inserted into derivatives of a bicistronic expression vector 16 (pMC) used previously for stable expression of genes in human cells. 17 Here the vector was modified to provide N-terminal fusion with a hemagglutinin (HA) epitope tag (YPYDVPDYA) linked by a five amino-acid spacer (PGPTR) or linked by an additional fusion to either the enhanced cyan or yellow fluorescent protein (CFP/YFP) with a seven amino-acid spacer (KQKVMNH). 18 All new constructs were checked by DNA sequencing. To facilitate simultaneous visualization of ITK and ITK R29H in human cells, a tricistronic expression vector was generated, in which HA-CFP-ITK R29H was placed in the first and HA-YFP-ITK in the second cistron, followed by the puromycin-resistance gene Puromycin N-acetyl-transferase in the third cistron.
Plasmid construction
Calcium measurements and fluorescence-activated cell sorting analyses Basically, calcium flux analyses in human T cells 19 as well as immunophenotyping by flow cytometry 7 were performed as described previously. Further details of these methods including complementation analyses in Itk knockout mice 20 and antibody descriptions are provided as supplementary data.
Detailed protocols for all other methods are provided as supplementary information.
RESULTS

Occurrence of ITK mutations in EBV-LPD patients
Since the initial discovery of ITK as a cause for an insufficient immune response to EBV in two girls, 7 we sequenced all exons of the ITK gene in 46 patients with EBV-LPD (lymphoproliferative disorders), 33 with clinical ALPS, 40 with suspicion of a congenital Hemophagocytic syndrome (hemophagocytic lymphohistiocytosis, HLH) and 12 children with common variable immunodeficiency.
Although the latter cohorts only harbored some heterozygous base exchanges (ALPS: ITK  V466V SNP rs17595896 or ITK  V587I SNP  rs56005928---one patient each, HLH no exchanges, common  variable immunodeficiency: one heterozygous ITK  Y578H ) , we identified two patients with homozygous ITK mutations among the EBV-LPD cohort. Beneath mutations in the SH2 domain of ITK that we found in our two index patients 7 (ITK R335W ) or a 32-residue truncation of the catalytic domain (ITK Y588X ) in three patients from Palestine (patients no. 3 --5), 21 we now identified mutations in the pleckstrin homology (PH) domain (ITK R29H patient no. 6 originating from Morocco) and another premature stop codon in the kinase domain of ITK in a girl originating from India (ITK D500T,F501,L,M503X patient no. 7). Figures 1a and b show the sequencing results for these newly identified patients no. 6 and 7. Patient no. 6 originates from a consanguineous family, but as patient no. 7 was a street child, who had been adopted by a Finnish family, we were not able to reconstruct her family tree. An overview of all ITK mutations assigned to its protein domains is illustrated in Figure 1c .
Clinical features of patients with ITK mutation Seven ITK-deficient patients from four unrelated families have been identified so far. For detailed patient characteristics please see Table 1 , and the clinical reports of the Turkish 7 and the Palestinian 21 family. The patients between the age of 3 and 11 years presented with persistent symptoms of infectious mononucleosis including recurrent febrile episodes and lymphadenopathies accompanied by extremely high EBV viral load in the blood. Further, EBV-related symptoms like hepatosplenomegaly, bilineage cytopenia or autoimmune phenomena were observed in some of the patients at onset or during the course of the disease (Table 1 ). Remission after different treatment concepts including virostatic agents, corticosteroids, rituximab or chemotherapy was only brief, and without hematopoietic stem cell transplantation, which has been performed in two patients (patients no. 5 and 7), the disorder has shown to be fatal. Relapse of LPD or lymphoma was always accompanied or preceded by reactivation of the highly replicative EBV infection. Of note, a pulmonary involvement with large interstitial nodules was observed in the majority of patients, as it is known from other EBV-related pathologies like lymphomatoid granulomatosis. Because of intermittent respiratory symptoms, lungs were frequently examined by X-ray, CT or PET-CT scans (see Supplementary Figure S1 for patient no. 5) or even open lung biopsy (patient no. 7). We think that the inability to control EBV infection resulting in an initially polyclonal proliferation of EBVinfected B cells with consecutive malignant transformation seems to be the main pathology in ITK deficiency.
Common immunological features in ITK-deficient patients are a progressive hypogammaglobulinemia and a progressive loss of CD4 þ T cells with a declining proportion of naive phenotype cells. Apart from EBV, patient no. 1 had BK virus and Pneumocystis jirovecii infection shortly before her death. Patients no. 4 and 5 revealed recurrent common respiratory viral infections in their history. Patient no. 6 repeatedly showed copies of CMV in serum and bronchoalveolar fluid. Invariant natural killer T cells were measured once in four of the patients and found to be low in all of them (Table 1 and Figure S1c) .
No asymptomatic and EBV-seronegative ITK-deficient person has been identified so far. Therefore, we do not know whether ITKdeficient patients are prone to develop LPD and lymphoma or any immunological abnormalities in the absence of active EBVinfection.
Gene expression of human CD4 þ cells with ITK mutation resembles murine Itk À/À cells In order to perform additional experiments despite limited amounts of primary patient T lymphocytes, we transformed them to stable growth by Herpesvirus saimiri (HVS) infection. 22 First, we approached the question of whether our HVS-transformed cell lines harboring the ITK deficiency mimic the situation in murine Itk À/À T cells by gene expression analyses using Affymetrix gene arrays (Affymetrix, Santa Clara, CA, USA). At first, we analyzed unstimulated HVStransformed T cells of our index patient no. 2 (ITK R335W CD4 þ ) compared with healthy control HVS cells. The average from cells at three different culturing time points led to a set of 1499 annotated genes (Welch's T-test, Po0.05) showing significant misregulation in the ITK R335W cells when compared with HVS-transformed cells from healthy volunteers (data not shown).
Next, we compared our data with corresponding gene expression analyses previously done on murine Itk knock-out CD4 þ cells. 23 We correlated both the data sets (our 1499
annotated genes with 1320 in mice) and generated a list of common differentially expressed genes consisting of only 26 downregulated and 20 upregulated genes in unstimulated CD4-positive cells ( Figure 2a and Supplementary Table 1) . A functional clustering based on Gene Ontology terms confirmed a high functional similarity for mice and human cells, particularly for genes involved in key intracellular signaling pathways, for example, the release of sequestered calcium ion into cytosol (Supplementary Figure S2) . This is also supported by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses 24 revealing, for example, four common genes having a part in the calcium signaling pathway (KEGG id hsa04020: P2RX7, F2R, GNA15 and CAMK4) along with NFAT being a part of the TCR signaling pathway (KEGG id hsa04660). The high scoring similarities between human HVS cell lines and the murine Itk À/À cells in terms of expression profiling, suggest that these transformed patient cell lines may serve as a suitable model for subsequent calcium flux analyses.
Mutations in ITK impede calcium mobilization ITK is a crucial part of the TCR-mediated signaling cascade, which has been shown to be critically involved in calcium signaling in mouse T cells. 25 Thus, we assayed calcium response after TCR stimulation by CD3 antibodies in HVS patient T lymphocytes. Figure 2b shows representative measurements from at least three independent experiments. Cells from patients harboring either the R29H mutation in the PH domain, or the R335W mutation in the SH2 domain as well as the cells from patient no. 4 (ITK Y588X ), showed a clearly reduced or nearly absent calcium response in all Loss-of-function ITK mutations in EBV-LPD patients RM Linka et al experiments. The cells from patient no. 7 (ITK D500T,F501,L,M503X ) exhibited remarkable calcium flux ability---although with significant delay when compared with cells with wt ITK. In the light of the fact that the ITK mRNA of patient no. 7 was likely to be degraded due to nonsense-mediated mRNA decay and low protein stability (see below), it came as a surprise that her cells exhibited such a visible residual calcium response.
The premature stop codon in ITK from patient no. 7 results in low abundance of mRNA transcripts Premature stop codons in an adequate distance of 50 --55 nucleotides to an exon --exon boundary may lead to nonsensemediated decay of transcripts. 26 We used our HVS cells to analyze their ITK mRNA abundance by quantitative PCR. In the case of ITK Y588X the premature stop codon in exon 16 is located only 27 nucleotides upstream of the last exon --exon junction, and the mRNA measurement did not show significant differences to wt ITK mRNA. The situation is different for the ITK D500T,F501,L,M503X mutant, where the premature stop codon in exon 14 is followed by three exons. We found a strong reduction of the ITK mRNA from patient no. 7 down to about 25%, most likely due to nonsense-mediated decay, whereas the mRNA levels in all other variants were not dramatically changed (Figure 2c ). To exclude exon skipping events in ITK of patient no. 7 as a result of the mutation, we sequenced the relevant fragment of the corresponding cDNA (data not shown).
We next asked whether the protein variants are indeed expressed in patient cells. We again used our HVS model to show that the various ITK variants can be detected in most cases, except the largely truncated and presumably very weakly expressed ITK form of patient no. 7, which we could not detect behind the unspecific background of the antibody (Figure 2d ). These data are in good accordance with our mRNA measurements from the same cells and with our previous observation of mutant R335W of patient no. 2. Human wt but not mutated ITK rescues the diminished TCR-mediated calcium flux in murine Itk À/À cells To prove that the mutations identified in our patients really affect TCR-mediated calcium mobilization, we aimed to restore calcium flux by reintroducing the wt enzyme in ITK-deficient cells. Unfortunately, several attempts to do this assay in stably HVS-transformed cells failed. We did not succeed in infecting these HVS cells by using retroviral or lentiviral vector constructs. We therefore analyzed the ability to restore calcium signaling of our different ITK mutations (Figure 1c ) in murine Itk À/À T lymphocytes, 20 which have been shown to exhibit a clearly reduced but still residual (B60%) calcium response compared with wt mice. 27 Cells from isolated thymus were infected with retroviral vectors containing green fluorescent protein as a marker for ITK expression and analyzed for calcium response after TCR stimulation. Figure 3e shows Figure 1c . Although the protein half-life measured with HAtagged protein variants may not exactly reflect those of endogenous proteins in primary T cells, we confirmed at least a significant impact of the mutations on the stability (Figure 3a and diagram in Figure 3b ; the corresponding data are provided in the Supplementary Table 2) . We determined the half-life of wt ITK to be 107 min, whereas each mutant exhibited a destabilizing effect leading to a 25% reduction for the half-life of ITK R335W (80.5 min), 41% reduction for ITK Y588X (63 min), 39% reduction for ITK
R29H
(65 min) and 69% reduction for ITK D500T,F501,L,M503X (33 min), respectively. These data also suggest that, in addition to its mRNA degradation, the ITK protein of patient no. 7 is subjected to rapid degradation, probably as a result of misfolding due to its incomplete C terminus.
The R29H mutation impedes the membrane targeting of ITK Patient no. 6 harbors a point mutation in the pleckstrin homology domain of ITK, a domain that is involved in ITK membrane targeting. 28 Therefore, we first asked for the impact of this mutation on the structure of the PH domain in silico. We modeled a structure of the ITK PH domain in inositol --phosphate complex based on the crystal structure of the PH domain of BTK, 29 which is also a member of the TEC kinase family. This model enabled us to compare both ITK PH wt and PH R29H according to their interaction with the inositol --phosphate moiety. As shown in Figure 4a To verify this observation experimentally, we used a cell-free phospholipid affinity assay analyzing the binding of purified ITK PH wt and PH R29H proteins to phospholipids. Remarkably, ITK PH wt bound with the highest specificity to phosphatidylinositol monophosphates, which are a substantial part of cellular membranes, 30 an interaction that was dramatically reduced in the case of the ITK PH R29H mutation (Figure 4b ). An interaction with phosphatidylinositol di-and tri-phosphates, although rather weak, was detectable for ITK PH wt only, but not at all in the case of the R29H mutant (longer exposure not shown). The putative loss 1 --5 ) or all five ITK constructs depicted in Figure 1c (lanes 6 --30) were subjected to pulse-chase analyses. Cells were cultured in medium containing 35 S-labeled amino acids for 20 min ('pulse') and 'chased' up to 30, 60, 120 and 240 min. HA-ITK proteins were immunoprecipitated, separated by SDS --polyacrylamide gel electrophoresis and exposed to X-ray films. (b) Normalized mean values of at least two experiments were plotted against time. Owing to ongoing translation and protein folding after time point zero (sometimes observed as an uptake of band intensities), we normalized our measurements to the values at 30 min. Calculated half-life times (t 1/2 ) are shown (for details see Materials and Methods section and Supplementary Table 2) ; reductions compared with wt are given in brackets.
of the membrane targeting function in ITK R29H was subsequently also confirmed using the full-length protein in living cells, visualized as fusions with fluorescent proteins. N-terminally green fluorescent protein-tagged full-length ITK has previously been shown to maintain function and behavior. 31 Figure 4d shows representative images of living HEK 293 cells stably coexpressing EYFP-ITK and ECFP-ITK R29H from the same polycistronic mRNA. The wt ITK shows a homogenous staining of the cellular membrane, whereas the mutated ITK R29H protein does not. We made the same observation when the human sarcoma cell line HT-1080 was used instead of HEK 293 (data not shown). Interestingly, an analog ITK mutant has been tested previously, carrying a cysteine at position 29 instead of histidine (ITK R29C ). R29C also impedes membrane recruitment of ITK as demonstrated by exclusive staining of the cytoplasm excluding the cellular membranes. 32 These results collectively suggest that ITK R29H lost its ability to recruit to the plasma membrane both in vitro and in vivo.
DISCUSSION
We show that germline mutations in ITK occur in both the sexes and in the children of diverse racial backgrounds. Our mutational screening data establish ITK deficiency as a separate molecular entity, which clinicians should consider in children with B cell LPD. The seven patients identified so far all presented primarily with massive EBV þ B-cell lymphoproliferation although its specific histological classification as B cell LPD, EBV þ Hodgkin's lymphoma or LCBL/lymphomatoid granulomatosis clearly varied. As seen in patients no. 4 and 6, autoimmunity may occur concomitantly and probably indicates an altered T-cell development, which has nicely been documented in Itk À/À mice, both in the CD4 þ and CD8 þ compartment. 9,10,33 --36 We think that ITK deficiency is clinically clearly distinct from SAP and XIAP deficiency, two well-known X-linked primary immunodeficiencies that often present as fulminant infectious mononucleosis or HLH after primary infection with EBV. 37, 38 ITK-deficient patients showed high EBV viral load, as it is sometimes seen in other primary T-cell deficiencies, for example, Wiskott --Aldrich syndrome or hypomorphic Artemis mutations. SAP-and XIAP-deficient patients are prone to the development of HLH, mostly with rather low EBV copy numbers or sometimes even in complete absence of EBV. SAP-deficient patients primarily develop Burkitt's lymphomas of the ileocecal region, whereas Hodgkin's lymphomas seem to be more prominent in the ITK-deficient cohort. XIAP deficiency may lead to chronic hemorrhagic colitis but not to lymphoma development. 37 As no asymptomatic and EBV-seronegative ITKdeficient person has been identified yet, we do not know whether ITK-deficient patients are intrinsically susceptible to develop lymphoma or dysgammaglobulinemia also in the absence of EBV infection. All three disorders have in common that they show a strong reduction of invariant Natural killer T cells, corroborating their immune-modulatory role in EBV defense. However, the occurrence of additional viral infections point to a more general, not purely EBV-specific immune deficiency in our patients. This situation is reminiscent to what can be seen in ITK-deficient mice that are unable to control a number of different infectious agents.
12,13 When we consider BTK and ITK as close relatives expressed in B or T lymphocytes, respectively, the mutational spectrum appears to be similar. 39 We found missense, nonsense and indel mutations spanning all protein domains of ITK. The different mutations clearly have different impact on the ITK function, but all data favor a loss-of-function mechanism.
The M503X mutant may likely be subjected to nonsensemediated mRNA decay because it is located upstream of an exon --exon junction in an appropriate distance. 26 The strongly reduced protein half-life when overexpressed in HEK293 cells and its virtual absence in HVS-transformed cells additionally argue for a very low intracellular abundance. Why M503X then exhibited a delayed but still significant calcium response after TCR stimulation, despite its low protein abundance, whereas the smaller truncated variant Y588X showed much less calcium signal? Both the proteins could still harbor a basic kinase activity, as the active site of ITK has been mapped to be upstream of the truncations (amino acids 376 --435). 40 The complex regulation of the second messenger Ca 2 þ depends on the relation of the individual TCR signaling components to each other, mode and strength of TCR activation, timing, and the calcium storage pools itself. One possible explanation could be the presence of Ca-flux inhibitory regions, for example, the Tyr-512 residue, located in the truncated region of patient no. 7. Tyr-512 has been shown to be phosphorylated by LCK, 40, 41 thought as an important mechanism in ITK regulation. LCK is a specific target of the HVS tyrosine-kinase-interacting protein (Tip). Strong overexpression of Tip inhibits the rise of intracellular calcium concentration and this effect is largely dependent on its interaction with LCK. 42 In HVS cells, the complex interplay between Tip, LCK and ITK may well be influenced when intracellular ITK level falls down under a critical threshold. Additionally, this low abundancy might also favor a redundant pathway in the HVS cells as assumed from several knock out studies. 43 Of note, like all other ITK mutants, M503X is unable to rescue the defective calcium response of ITK-deficient mice, pointing to subtle species --specific differences. From a diagnostic point of view, genetic ITK mutation analyses may be more valid than functional assessment of Ca 2 þ response. We show that the PH domain of wt ITK directly associates with the highest specificity to phosphoinositol monophosphates in vitro, but only to a significant lesser extend with their higher order di-or tri-phosphate derivates. In contrast, the PH domain of BTK preferentially binds to phosphatidylinositol (3, 4, 5) triphosphate over other phosphorylated forms, including monophosphates. 44 The ITK R29H mutant exhibited dramatically reduced membrane binding in living cells, which is also consistent with a pronounced impact on its ability to induce sufficient calcium flux in human cells. Huang et al. 45 recently showed by a set of very elegantly performed experiments how the complex interplay between freely soluble inositol polyphosphates (for example, IP4) and phosphatidylinositol(3,4,5)triphosphate influences recruitment of ITK to the membrane. We were able to confirm this observation for the ITK PH wt by utilizing a phospholipids array strip at concentrations 10 6 -fold lower than that used by Huang et al. In addition, we identified phosphatidylinositol monophosphates as the most specific partners for the PH domain of ITK. Under inactive conditions, ITK remains as a monomer within the cytoplasm of a T cell. 32, 46 Following TCR activation, ITK becomes activated and incorporated into a multi-protein signalosome by membrane binding via its PH domain. 11 It seems likely but remains to be seen whether R29H or other mutations also differently affect ITK kinase activity.
We are aware of the fact that mutations of the homolog Arg-28 of BTK have frequently been shown to be involved in X-linked agammaglobulinemia. The BTKbase lists a total of 28 patients harboring mutations of Arg-28 (ref. 5) of which 17 were R28H ( Table 2 ). In addition, a patient with a frameshift indel mutation leading to a premature stop codon in BTK, Y627X, 47 completely resembles the Y588X mutation in the ITK protein of patients no. 3 --5. Another patient with X-linked agammaglobulinemia is reported to have a frameshift deletion that also leads to a premature stop codon, F540X, a mutation only two amino acids away from the corresponding premature stop-codon mutation of our patient no. 7.
Thus, we think that the large collection of mutations now assembled into the BTKbase since 1993 may serve as a paradigm for the ITK deficiency as well. The clinical course of patients with ITK deficiency may be more variable and they may be more difficult to treat than patients with Bruton's disease. 
